ClinicalTrials.gov
ClinicalTrials.gov Menu

A Study to Evaluate a Single IM Dose of Motavizumab Treatment of Children With RSV (Respiratory Syncytial Virus) Illness

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00435227
Recruitment Status : Completed
First Posted : February 14, 2007
Last Update Posted : July 4, 2012
Sponsor:
Information provided by:
MedImmune LLC

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2008
  Actual Study Completion Date : July 2008
  Certification/Extension First Submitted : July 2, 2012